Twitter
Advertisement

Ranbaxy settles dispute with Takeda Pharma

Takeda has granted Ranbaxy a non-exclusive royalty free license for its US patents covering Actos, Ranbaxy, which is majority owned by Daiichi Sankyo.

Latest News
Ranbaxy settles dispute with Takeda Pharma
FacebookTwitterWhatsappLinkedin

Ranbaxy Laboratories  has settled litigation with Japan's Takeda Pharmaceutical over a generic equivalent version of anti-diabetic drug Actos.                                           

Takeda has granted Ranbaxy a non-exclusive royalty free license for its US patents covering Actos, Ranbaxy, which is majority owned by Daiichi Sankyo, said in a statement on Monday.

Find your daily dose of news & explainers in your WhatsApp. Stay updated, Stay informed-  Follow DNA on WhatsApp.
Advertisement

Live tv

Advertisement
Advertisement